Conclusions
We believe that PCO patients can achieve good results in IVF cycles, provided that stimulation protocols appropriate to their hormonal profiles are used.
The dose of gonadotropin used seems to be more important than the type of gonadotropin. If there is a risk of ovarian hyperstimulation, it is useful to employ one of the strategies recommended to prevent development of genuine OHS, which may endanger the patient’s health.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asch RH, Ivery G, Goldsman M, Frederick JL, Stone SC, Balmaceda JP: The use of intravenous albumin in patients at high risk for severe OHSS. Hum Reprod 1993;8:1015–1020
Barri PN: Respuesta Anomala a la Estimulacion de la Maduracion Folicular en FIV. Doctoral thesis, Universidad de Barcelona, Barcelona
Balasch J, Jove Y, Moreno V, Civico S, Puerto B, Vanrell JA: The comparison of two GnRHa in an IVF program. Fertil Steril 1992;58(5):991–994
Balen AH, Tan SL, Jacobs HS: Hypersecretion of luteinizing hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082–1089
Berg C, Hamberger L: Cumulative birth rates by IVF including cryopreservation of all embryos. Assist Reprod Rev 1995;5:195–200
Buyalos RP, Lee CT: Polycystic ovary syndrome: Pathophysiology and outcome with in vitro fertilization. Fertil Steril 1996;65:1–10
Homburg R, Levy T, Ben-Rafael Z: Adjuvant growth hormone for induction of ovulation with GnRHa and gonadotropins in polycystic ovary syndrome: A randomized, doubleblind, placebo controlled trial. Hum Reprod 1995;10:2550–2553
Homburg R, Levy T, Berkovitz D, Farchi J, Feldelberg D, Ashkenazi J: GnRH agonist reduces the miscarriage rate for pregnancies achieved in women with PCO syndrome. Fertil Steril 1993;59:527–531
Howles C, MacNamee MG: Endocrine monitoring in assisted human conception. Br Med Bull 1990;46:616–627
Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 1990;336:1141–1144
Remohi J, Vidal A, Pellicer A: Oocyte donation to low responders to a conventional ovarian stimulation for in vitro fertilization. Fertil Steril 1993;59:1208–1215
Shoham Z, Weissman A, Barash A, Borenstein R, Schater M, Insler V: Intravenous albumin for the prevention of severe OHSS in an IVF program. A prospective, randomized, placebo-controlled study. Fertil Steril 1994;62:137–142
Simon C, Valbuena D, Cano F, Remohi J, Pellicer A: Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol concentrations in high and normal responder patients. Hum Reprod 1995;10(9):2432–2437
Tarlatzis BC, Grimbizis G: Asisted reproduction techniques in polycystic ovarian syndrome. Ann NY Acad Sci 1993;687:280–287
Tarlatzis BC, Grimbizis G, Pournaropoulos F, Lagos S, Spanos E, Mantelenakis S: The prognostic value of basal luteinizing hormone; follicule-stimulating hormone rational, in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 1995;10:2545–2549
Tarin JJ, Pellicer A: Consequences of high ovarian response to gonadotrophins: A cytogenetic analysis of unfertilized human oocytes. Fertil Steril 1990;54:665–670
Urman B, Pride SM, Yven BH. Management of overstimulated gonadotropin cycles with a controlled drift period. Hum Reprod 1992;7:213–217
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barri, P.N., Coroleu, B., Martinez, F. et al. Treatment of polycystic ovary patients undergoing IVF. J Assist Reprod Genet 14, 10–12 (1997). https://doi.org/10.1007/BF02765743
Issue Date:
DOI: https://doi.org/10.1007/BF02765743